Innovation, Research
Therapeutic innovation in the fight against pulmonary arterial hypertension
… cardiopulmonary disease characterised by intense remodelling of the small-calibre pulmonary arteries. Either … (without a proven cause) or hereditary (linked to a genetic abnormality), it affects approximately 15 people per … Hypertension: Physiopathology and Therapeutic Innovation laboratory (HPPIT - Université Paris-Saclay, Inserm), in …Published on: